As concerns mount over the spread of the coronavirus and the availability of medical supplies, should the threat of infection increase, U.S. Senator Josh Hawley (R-Mo.) is introducing legislation to help guarantee the United States medical product supply chain is functioning well.
The Medical Supply Chain Security Act comes behind reports by news outlets of a potential drug shortage due to the effect of the coronavirus on Chinese drug manufacturers.
